Article Details

Empyrean Neuroscience launches with $22M to target CNS disorders - Labiotech.eu

Retrieved on: 2022-10-18 13:45:53

Tags for this article:

Click the tags to see associated articles and topics

Empyrean Neuroscience launches with $22M to target CNS disorders - Labiotech.eu. View article details on HISWAI: https://www.labiotech.eu/trends-news/empyrean-neuroscience-launches-to-target-cns-disorders/

Excerpt

Empyrean Neuroscience has launched to advance a pipeline of neuroactive compounds targeting disorders of the central nervous system.

Article found on: www.labiotech.eu

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up